Meniere disease (endolymphatic hydrops, Meniere's syndrome)
Peripheral vertigo · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Recurrent spontaneous vertigo attacks (20 min to 12 h) with fluctuating sensorineural hearing loss, tinnitus and aural fullness, attributed to endolymphatic hydrops. Diagnosis is clinical (Barany Society criteria). ED role: manage the acute attack, exclude dangerous mimics, and refer to ENT for long-term control.
Red flags
- Persistent (not episodic) vertigo, new neurological signs — central cause
- Unilateral progressive hearing loss/tinnitus without vertigo — vestibular schwannoma (needs MRI)
- Sudden sensorineural hearing loss (<72h) — ENT emergency for steroids
- Vascular risk + first acute vertigo — exclude posterior stroke
Assessment
Differential diagnosis
- Vestibular migraine (major mimic — overlapping features)
- Vestibular neuritis / labyrinthitis — separate entry
- BPPV — separate entry
- Posterior circulation TIA/stroke
- Acoustic neuroma / vestibular schwannoma
- Autoimmune inner ear disease, syphilis (rare)
- Perilymph fistula
Investigations
- Clinical diagnosis (>=2 spontaneous vertigo episodes 20 min-12 h + audiometrically confirmed low-mid frequency SNHL in affected ear + fluctuating aural symptoms)
- Pure-tone audiometry (low-to-mid frequency SNHL, fluctuating) — key test, arrange via ENT
- MRI internal auditory meatus to exclude vestibular schwannoma if unilateral hearing loss
- Exclude central/vascular causes if atypical (HINTS if acute vestibular syndrome)
- Bloods if indicated: syphilis serology, autoimmune screen, TFT
Management
- Confirm episodic pattern with cochlear symptoms (hearing loss, tinnitus, fullness) — distinguishes from BPPV/neuritis
- Acute attack: antiemetic + vestibular suppressant for symptomatic relief; reassure attack is self-limiting
- Exclude stroke/central cause if first severe attack or red flags
- Long-term (ENT-led): lifestyle — low-salt diet, reduce caffeine/alcohol/stress; betahistine often used (evidence modest); consider thiazide/diuretic
- Step-up (specialist): intratympanic steroids, intratympanic gentamicin (ablative), diuretics, pressure (Meniett) device, endolymphatic sac surgery in refractory cases
- Audiology and ENT referral; hearing aid if progressive loss
- Counsel re driving (attacks of incapacitating vertigo — notify licensing authority) and safety
Drugs & doses
Acute attack: prochlorperazine 12.5 mg IM then 5-10 mg PO TDS (buccal 3 mg BD option); OR cyclizine 50 mg PO/IM TDS [verify local dose]
Antiemetic: ondansetron 4-8 mg or metoclopramide 10 mg if vomiting
Prophylaxis (ENT-led): betahistine 16 mg PO TDS (or 24 mg BD), titrate [verify local — evidence modest]
Diuretic option (specialist): bendroflumethiazide or acetazolamide / thiazide + low-salt diet [verify local]
Refractory (specialist): intratympanic dexamethasone or intratympanic gentamicin
Disposition
Discharge after acute attack settles with antiemetic and ENT/audiology referral. Admit only if intractable vomiting/dehydration or diagnostic uncertainty needing stroke work-up.
Complications & pitfalls
- Progressive permanent sensorineural hearing loss
- Chronic imbalance, drop attacks (Tumarkin otolithic crisis)
- Anxiety/depression, falls, driving restriction
- Bilateral disease in a minority
Exam pearls
- Vertigo + fluctuating hearing loss + tinnitus/fullness = Meniere; vertigo without cochlear symptoms is not
- Vestibular migraine is the commonest mimic — ask about headache/photophobia and migraine history
- Betahistine is widely used but a large RCT (BEMED, BMJ 2016) showed no benefit over placebo — counsel accordingly [verify local]
- Unilateral hearing loss warrants MRI IAM to exclude schwannoma
- Acute attacks are self-limiting; manage symptomatically and refer ENT for disease control
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.